Moderna's messenger RNA vaccine is being studied in combination with Merck's Keytruda to treat patients with high-risk melanoma, the deadliest form of skin cancer, in a phase two trial.
Moderna's vaccine is designed to trigger the immune system to deploy killer T cells that target the specific mutations of a patient's tumors. Merck's Keytruda is a monoclonal antibody, administered as an injection, that prevents certain cell proteins from stopping T cells from going on the attack.
The companies originally entered the agreement in 2016, but Merck is now exercising its option through a $250 million payment to Moderna. Merck will collaborate on the development and commercialization of the product. The companies will share all costs and profits equally.after developing one of the most successful vaccines against Covid-19 in collaboration with the U.S. National Institutes of Health.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Scientists pan analysis Florida's surgeon general posted on COVID-19 vaccinesVaccine experts are pushing back on an analysis published by Florida's surgeon general that warns COVID-19 vaccines increase the risk of cardiac-related deaths in young men, calling the study poorly designed and dangerously misleading.
Weiterlesen »
Should Older Patients With Syncope Still Drive?Findings suggest that patients visiting the ED with first-episode syncope have no higher risk of future car crashes.
Weiterlesen »
Colonoscopies may not be as effective as thought, study suggests. Doctors disagree.Large, European study found colonoscopies didn't reduce the risk of colon cancer deaths.
Weiterlesen »
The Truth About Soy and Breast CancerYou may have heard that you shouldn’t eat soy if you are at risk for breast cancer. But then you see headlines saying that it could protect against the disease. So what’s the truth? Find out here:
Weiterlesen »
Making Strides Against Breast Cancer returns to Chicago's Soldier FieldFunds raised through the Making Strides movement allow the American Cancer Society to serve breast cancer patients and their families where and when they need it most.
Weiterlesen »